Tu1879 EFFICACY AND SAFETY OF LONG-TERM TREATMENT WITH USTEKINUMAB IN MODERATE-SEVERE ULCERATIVE COLITIS PATIENTS WITH DELAYED RESPONSE TO USTEKINUMAB INDUCTION: RESULTS FROM THE UNIFI 2-YEAR LONG-TERM EXTENSION

Authors :: Tadakazu Hisamatsu
Maria T. Abreu
Rupert W. Leong
Ellen Scherl
Silvio Danese
Colleen Marano
David Rowbotham
Christopher D. O'Brien
Yiying Zhou
Laurent Peyrin-Biroulet
Ramesh P. Arasaradnam
Jewel Johanns
Bruce E. Sands
Hongyan Zhang
Source :: Gastroenterology. 158:S-1201
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Delayed response
Pediatrics
medicine.medical_specialty
Long term treatment
Hepatology
business.industry
Gastroenterology
medicine.disease
Ulcerative colitis
Term (time)
Ustekinumab
medicine
business
medicine.drug

Tools